from Yahoo Finance https://ift.tt/2X89X3h
-
Hedge Funds Have Never Been This Bullish On The Sherwin-Williams (SHW)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
from Yahoo Finance https://ift.tt/2M1KPF5
-
Novartis inks deal to make Mass General Brigham’s COVID-19 vaccine candidate
Novartis’s gene therapy unit AveXis has signed a manufacturing deal to help produce a novel genetic COVID-19 vaccine candidate being developed by U.S. researchers in Massachusetts, a spokeswoman for the Swiss drugmaker confirmed on Thursday. Massachusetts General Hospital and Massachusetts Eye and Ear are developing a vaccine candidate that relies on adeno-associated viral (AAV) vector technology to produce immunity. AveXis, which makes Novartis’s $2.1 million-per-patient gene therapy Zolgensma for the hereditary disease spinal muscular atrophy, is contributing technology, expertise and its manufacturing supply chain at no cost, it said.
from Yahoo Finance https://ift.tt/3c9myYb
The Latest
-
The Koala Company jumps to profit in FY26: Earnings highlight strong growth
-
I’d buy 164,557 shares of this ASX stock to aim for $500 a week of passive income
-
Tabcorp lifts FY26 profit, unveils new tech acquisition
-
WiseTech Global share price: FY26 earnings soar 79% on e2open acquisition